Cynosure Company Profile (NASDAQ:CYNO)

About Cynosure

Cynosure logoCynosure Inc. (Cynosure) develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve gynecologic health. The Company operates through aesthetic treatment products and services segment. It markets radiofrequency (RF) energy sourced medical devices for precision surgical applications, such as facial plastic and general surgery; gynecology; ear, nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry, and proctology. The Company's product portfolio utilizes a range of energy sources, including Alexandrite, diode, neodymium-doped yttrium aluminum garnet (Nd: YAG), pulse dye, Q-switched lasers, intense pulsed light and RF technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: CYNO
  • CUSIP: 23257720
Key Metrics:
  • Previous Close: $51.08
  • 50 Day Moving Average: $52.45
  • 200 Day Moving Average: $46.97
  • Trailing P/E Ratio: 60.31
  • Foreward P/E Ratio: 27.17
  • P/E Growth: 1.74
  • Market Cap: $1.21B
  • Outstanding Shares: 23,731,000
  • Beta: 1.66
Additional Links:
Companies Related to Cynosure:

Analyst Ratings

Consensus Ratings for Cynosure (NASDAQ:CYNO) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $58.60 (14.72% upside)

Analysts' Ratings History for Cynosure (NASDAQ:CYNO)
DateFirmActionRatingPrice TargetDetails
7/28/2016Brean CapitalReiterated RatingBuy$54.00 -> $60.00View Rating Details
7/27/2016Northland SecuritiesSet Price TargetBuy$55.00 -> $60.00View Rating Details
7/27/2016Stifel NicolausReiterated RatingBuy$57.00 -> $62.00View Rating Details
7/27/2016Maxim GroupBoost Price TargetBuy$60.00 -> $66.00View Rating Details
4/27/2016Leerink SwannReiterated RatingBuyView Rating Details
4/29/2015Northcoast ResearchInitiated CoverageBuy$41.00View Rating Details
3/6/2015Tigress FinancialInitiated CoverageBuyView Rating Details
(Data available from 8/28/2014 forward)


Earnings History for Cynosure (NASDAQ:CYNO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2016Q216$0.29$0.36$101.31 million$110.30 millionViewListenView Earnings Details
4/26/2016Q116$0.14$0.19$85.78 million$94.70 millionViewListenView Earnings Details
2/9/2016Q415$0.38$0.42$95.01 million$102.40 millionViewListenView Earnings Details
10/27/2015Q315$0.18$0.21$76.68 million$78.40 millionViewListenView Earnings Details
7/28/2015Q215$0.29$0.30$82.71 million$83.70 millionViewListenView Earnings Details
5/5/2015Q1$0.09$0.15$70.87 million$74.90 millionViewListenView Earnings Details
2/10/2015Q414$0.39$0.36$83.01 million$86.30 millionViewListenView Earnings Details
10/28/2014Q314$0.24$0.25$69.94 million$71.50 millionViewListenView Earnings Details
7/29/2014Q214$0.29$0.32$71.15 million$72.60 millionViewListenView Earnings Details
5/6/2014Q1$0.23$0.19$64.70 million$62.00 millionViewListenView Earnings Details
2/12/2014Q413$0.19$0.39$67.80 million$74.50 millionViewListenView Earnings Details
10/29/2013Q313$0.19$0.23$61.60 million$60.70 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.20$0.29$46.96 million$50.09 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.13$0.12$38.51 million$10.70 millionViewListenView Earnings Details
2/12/2013Q4 2012$0.23$0.27$40.98 million$47.70 millionViewListenView Earnings Details
10/23/2012$0.12$0.25ViewN/AView Earnings Details
7/24/2012$0.12$0.20ViewN/AView Earnings Details
5/1/2012($0.02)$0.06ViewN/AView Earnings Details
2/14/2012$0.05$0.08ViewN/AView Earnings Details
10/25/2011$0.04($0.06)ViewN/AView Earnings Details
5/3/2011($0.05)($0.15)ViewN/AView Earnings Details
2/15/2011($0.03)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cynosure (NASDAQ:CYNO)
Current Year EPS Consensus Estimate: $1.34 EPS
Next Year EPS Consensus Estimate: $1.88 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.13$0.26$0.18
Q2 20165$0.27$0.37$0.31
Q3 20165$0.21$0.35$0.30
Q4 20163$0.49$0.71$0.57
Q1 20173$0.22$0.33$0.29
Q2 20173$0.49$0.54$0.51
Q3 20173$0.31$0.44$0.39
Q4 20173$0.65$0.84$0.72
(Data provided by Zacks Investment Research)


Dividend History for Cynosure (NASDAQ:CYNO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Cynosure (NASDAQ:CYNO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016Michael R DavinChairmanSell12,062$53.35$643,507.70View SEC Filing  
8/15/2016Timothy W BakerCFOSell5,834$53.35$311,243.90View SEC Filing  
8/11/2016Michael R DavinChairmanSell4,222$53.18$224,525.96View SEC Filing  
8/11/2016Timothy W BakerCFOSell2,041$53.19$108,560.79View SEC Filing  
5/13/2016Douglas J DelaneyVPSell12,299$46.60$573,133.40View SEC Filing  
5/13/2016Michael R DavinCEOSell26,271$46.59$1,223,965.89View SEC Filing  
5/13/2016Timothy W BakerCFOSell12,451$46.60$580,216.60View SEC Filing  
4/18/2016Douglas J DelaneyVPSell15,890$45.01$715,208.90View SEC Filing  
4/18/2016Michael R DavinCEOSell74,729$45.31$3,385,970.99View SEC Filing  
4/18/2016Timothy W BakerCFOSell14,008$45.02$630,640.16View SEC Filing  
4/14/2016Douglas J DelaneyVPSell24,488$45.02$1,102,449.76View SEC Filing  
4/14/2016Michael R DavinCEOSell61,377$45.01$2,762,578.77View SEC Filing  
4/14/2016Timothy W BakerCFOSell39,857$45.02$1,794,362.14View SEC Filing  
4/13/2016Michael R DavinCEOSell72$45.00$3,240.00View SEC Filing  
4/6/2016Douglas J DelaneyVPSell4,408$45.08$198,712.64View SEC Filing  
4/6/2016Michael R DavinCEOSell4,869$45.11$219,640.59View SEC Filing  
4/6/2016Timothy W BakerCFOSell4,413$45.08$198,938.04View SEC Filing  
4/4/2016Douglas J DelaneyVPSell66,626$45.47$3,029,484.22View SEC Filing  
4/4/2016Michael R DavinCEOSell66,259$45.61$3,022,072.99View SEC Filing  
4/4/2016Timothy W BakerCFOSell53,297$45.60$2,430,343.20View SEC Filing  
12/31/2015Michael R. DavinCEOSell200$45.00$9,000.00View SEC Filing  
12/31/2015Timothy W. BakerCFOSell100$45.00$4,500.00View SEC Filing  
6/1/2015Ettore V BiagioniDirectorSell24,000$36.25$870,000.00View SEC Filing  
5/20/2015Douglas J DelaneyVPSell89,000$38.01$3,382,890.00View SEC Filing  
5/20/2015Michael R DavinCEOSell151,000$38.07$5,748,570.00View SEC Filing  
4/23/2015Michael R DavinCEOSell6,991$33.04$230,982.64View SEC Filing  
4/10/2015Michael R DavinCEOSell44,677$33.01$1,474,787.77View SEC Filing  
4/9/2015Douglas J DelaneyVPSell28,335$33.01$935,338.35View SEC Filing  
4/9/2015Michael R DavinCEOSell70,000$32.00$2,240,000.00View SEC Filing  
4/8/2015Douglas J DelaneyVPSell45,000$32.00$1,440,000.00View SEC Filing  
1/9/2015Ettore V BiagioniDirectorSell12,000$30.09$361,080.00View SEC Filing  
12/2/2014Ettore V BiagioniDirectorSell2,500$28.00$70,000.00View SEC Filing  
11/24/2014Ettore V BiagioniDirectorSell5,000$27.28$136,400.00View SEC Filing  
11/5/2013Marina HatsopoulosDirectorBuy3,000$22.60$67,800.00View SEC Filing  
9/5/2012Douglas J DelaneyVPSell16,904$27.65$467,395.60View SEC Filing  
9/5/2012Michael R DavinCEOSell16,770$27.65$463,690.50View SEC Filing  
9/5/2012Timothy W BakerCFOSell16,854$27.65$466,013.10View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Cynosure (NASDAQ:CYNO)
DateHeadline logoCynosure, Inc. breached its 50 day moving average in a Bearish Manner : CYNO-US : August 26, 2016 (NASDAQ:CYNO) - August 26 at 8:58 AM logoWill Cynosure, Inc. (NASDAQ:CYNO) Surprise This Quarter? - Investor Newswire (NASDAQ:CYNO) - August 25 at 4:35 PM logoAnalysts See Cynosure, Inc. (NASDAQ:CYNO) Reporting EPS Of $0.41 - (NASDAQ:CYNO) - August 21 at 4:18 PM
News IconCrowd Sentiment & Wall Street Views on Cynosure, Inc. (NASDAQ:CYNO)? - Post News (NASDAQ:CYNO) - August 20 at 5:34 AM
News IconConsensus Take: Cynosure, Inc. (NASDAQ:CYNO) Earnings & Ratings Watch - Post News (NASDAQ:CYNO) - August 19 at 3:38 PM logoCYNOSURE INC Financials (NASDAQ:CYNO) - August 16 at 4:38 PM
News IconCynosure Announces New Innovations for Melasma Treatment and Effective Body Contouring Laser Treatment at Cynosure APAC Forum (NASDAQ:CYNO) - August 16 at 6:58 AM
News IconLiposuction Surgery Devices Market Value Share, Supply Demand, share and Value Chain 2016-2026 (NASDAQ:CYNO) - August 13 at 4:31 PM
News IconDermatology Treatment Devices Market Driving Factors, Industry Analysis, Investment Feasibility and Trends (NASDAQ:CYNO) - August 12 at 4:35 PM logoCynosure, Inc. (CYNO) Ownership Up in Latest Report from Dimensional Fund Advisors Lp - Finance Daily (NASDAQ:CYNO) - August 10 at 8:15 AM logoCynosure, Inc. (NASDAQ:CYNO) Quarterly Accounts Payable At $72.597 Millions - (NASDAQ:CYNO) - August 8 at 4:40 PM logoCYNOSURE INC Files SEC form 10-Q, Quarterly Report (NASDAQ:CYNO) - August 5 at 4:36 PM
News IconDermatology Devices Market Revenue and Value Chain 2016-2026 (NASDAQ:CYNO) - August 5 at 9:46 AM
News IconWorldwide Facial Rejuvenation Market expected to grow at a CAGR of 4.9% from 2015-2021, According to PMR Report (NASDAQ:CYNO) - August 2 at 4:41 PM logoLooking for Healthcare Stocks? Consider These Four (NASDAQ:CYNO) - August 2 at 4:41 PM logoCynosure, Inc. (NASDAQ:CYNO) Yearly Accounts Payable At $33.885 Millions - (NASDAQ:CYNO) - August 2 at 9:20 AM logoBrokers Issue Average Price Target Of 47.59 On Cynosure, Inc. (NASDAQ:CYNO) - FTSE News (NASDAQ:CYNO) - July 29 at 9:54 PM logoCynosure Inc. (CYNO) Hits New 52-week High During July 26 Session - (NASDAQ:CYNO) - July 28 at 5:32 PM logoCynosure Still Looks Attractive After A Bull Run - Seeking Alpha (NASDAQ:CYNO) - July 28 at 5:32 PM logoCynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016 (NASDAQ:CYNO) - July 28 at 10:41 AM logoCynosure Inc. (CYNO) Hits New 52-week High During July 26 Session (NASDAQ:CYNO) - July 28 at 10:41 AM logoCynosure Inc (NASDAQ:CYNO) nearing 52-week high, short interest stable - Street Report (NASDAQ:CYNO) - July 27 at 11:00 AM logo7:24 am Cynosure target raised to $66 rom $60 at Maxim Group (NASDAQ:CYNO) - July 27 at 7:24 AM logoCynosure Inc.: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter ... - The Wall Street Transcript (NASDAQ:CYNO) - July 26 at 10:37 PM logoEdited Transcript of CYNO earnings conference call or presentation 26-Jul-16 1:00pm GMT (NASDAQ:CYNO) - July 26 at 4:53 PM logoCynosure Receives Approval to Market SculpSure® in South Korea (NASDAQ:CYNO) - July 26 at 12:48 PM logoCynosure beats Street 2Q forecasts (NASDAQ:CYNO) - July 26 at 12:48 PM logoCynosure Inc.: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016 (NASDAQ:CYNO) - July 26 at 12:48 PM logoCynosure, Inc. (Nasdaq: CYNO) to Ring The Nasdaq Stock Market Closing Bell (NASDAQ:CYNO) - July 26 at 10:08 AM logoMed-Instrument Stocks to Post Earnings: EW, CYNO, GMED (NASDAQ:CYNO) - July 25 at 10:59 AM logoCynosure : To Host Second-Quarter 2016 Financial Results Conference Call On July 26 (NASDAQ:CYNO) - July 23 at 4:27 PM logoCYNOSURE INC : Change in Directors or Principal Officers (form 8-K) (NASDAQ:CYNO) - July 23 at 8:41 AM logoCYNOSURE INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CYNO) - July 22 at 4:32 PM
News IconFirms and Funds Increasing Their Stake in Cynosure, Inc. (NASDAQ:CYNO) - Engelwood Daily (NASDAQ:CYNO) - July 22 at 4:28 PM
News IconMedical aesthetics market to grow at a CAGR of 10.8% by 2020 scrutinized in new research (NASDAQ:CYNO) - July 22 at 9:49 AM logoSkincare Devices Industry Global Analysis by Region, vendors, Market challenge and Technology Forecasts 2022 (NASDAQ:CYNO) - July 22 at 9:49 AM
News IconInstitutions Increasing Their Positions in Cynosure, Inc. (NASDAQ:CYNO) - Engelwood Daily (NASDAQ:CYNO) - July 21 at 10:02 PM
News IconAnti-Ageing Market to Grow at a CAGR of 8.0% Through 2019 (NASDAQ:CYNO) - July 21 at 4:41 PM logoETF’s with exposure to Cynosure, Inc. : July 21, 2016 (NASDAQ:CYNO) - July 21 at 1:55 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Cynosure, Inc. (NASDAQ:CYNO) - TGP (NASDAQ:CYNO) - July 21 at 5:16 AM logoAesthetic Equipment Market - Global Industry Analysis, Growth, Trends, Forecast 2019 (NASDAQ:CYNO) - July 20 at 5:42 PM logoMajor Second Quarter Purchases for Cohen include Tesaro, Pernix (NASDAQ:CYNO) - July 20 at 5:42 PM logoBroker Outlook For Cynosure, Inc. (NASDAQ:CYNO) - Fiscal Standard (NASDAQ:CYNO) - July 20 at 9:52 AM
News IconInsight Capital Research & Management INC Increased Cynosure ... - Consumer Eagle (NASDAQ:CYNO) - July 19 at 9:51 PM
News IconCynosure, Inc. (NASDAQ:CYNO): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CYNO) - July 19 at 4:37 PM logoCynosure, Inc. (NASDAQ:CYNO) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CYNO) - July 19 at 10:39 AM
News IconStock in Positive Territory for the Quarter: Cynosure, Inc. (NASDAQ:CYNO) - Engelwood Daily (NASDAQ:CYNO) - July 19 at 10:39 AM logoCan Cynosure, Inc. (NASDAQ:CYNO) Surprise Analysts this Quarter? - Investor Newswire (NASDAQ:CYNO) - July 19 at 10:39 AM
News IconShare Performance Summary for: Cynosure, Inc. (NASDAQ:CYNO) - Press Telegraph (NASDAQ:CYNO) - July 19 at 10:39 AM logoCynosure Inc Realized Volatility Hits Elevated Level - CML News (NASDAQ:CYNO) - July 19 at 10:39 AM


Cynosure (NASDAQ:CYNO) Chart for Sunday, August, 28, 2016

Last Updated on 8/28/2016 by Staff